Reclast Side Effects May Include Increased Risk of Seizures: Case Report
A new case report warns of a possible link between Reclast bone drug infusions and an increased risk of seizures.
Tag Archives: Reclast
-
-
Study Questions Whether Fosamax And Similar Bone Drugs Provide Benefits After Seven Years of Use
A new study reveals that Fosamax and similar osteoporosis drugs failed to provide any benefits in preventing hip fractures after seven years of use.
-
Reclast Failed To Prevent Cartilage Loss In Knee Osteoarthritis: Study
A Reclast study's findings indicate the bone drug does no better than a placebo at preventing cartilage loss due to knee osteoarthritis, while still carrying significant risk of side effects.
-
Stop Using Fosamax, Actonel, Similar Drugs After Femur Fracture: Study
Individuals who have suffered a femur fracture while using Fosamax, Actonel or another bisphophonate medication can decrease their chances of having a second break if they simply stop taking the…
-
Femur Fracture Lawsuits Over Fosamax and Boniva, Reclast Sent to MDL
Lawsuits filed in federal court by individuals who allege that they suffered a femur fracture after taking a both Fosamax and Boniva, Fosamax and Reclast, or all three bisphosphonate drugs,…
-
Reclast Kidney Failure Side Effects Added to Label in U.S.
A new warning about the risk of kidney problems from Reclast will be added to the osteoporosis drug in the United States, nearly a year after doctors in Canada were…
-
Side Effects of Fosamax, Other Bisphosphonates To Be Reviewed by FDA
A panel of outside advisers to the FDA are scheduled to meet and review questions about the side effects of Fosamax and other osteoporosis drugs, which may increase the risk…
-
Reclast Kidney Damage Warning Issued in Canada, But Not in U.S.
A consumer watchdog is urging federal regulators to force Novartis to issue warnings in the United States about potential side effects of Reclast, an osteoporosis drug that has been linked…
-
Risk of Thigh Fractures Seen With Fosamax, Actonel, Other Bisphosphonates
Long-term use of oral bisphosphonates, such as Fosamax, Actonel and Reclast, increase the risk of rare, atypical thigh bone fractures, according to a new study.
